Continuous Terlipressin Infusion Improves Muscle Strength and Reduces Ascites in Cirrhosis: Study Dr Riya Dave13 Sept 2024 5:00 AM ISTResearchers found that continuous terlipressin infusion (CTI) significantly improved muscle strength, reduced ascites, and enhanced quality of life in...
Aldafermin Shows Promise in Reducing Liver Fibrosis in Compensated NASH Cirrhosis Dr Riya Dave30 Nov 2023 2:00 AM ISTA recent phase 2b trial has revealed promising results for aldafermin, an engineered analog of the human hormone FGF19, in treating compensated...
Lactulose Therapy Improves Sleep and Activity Impairment in Cirrhosis Patients Dr Riya Dave13 Oct 2023 8:00 PM ISTA recent 28-day randomized trial assessed the impact of crystalline lactulose therapy on patient-reported outcomes (PROs) in cirrhosis patients with...
'New Affirmative And Non-Stigmatizing "Fatty" Liver Disease Nomenclature announced by Multinational Liver Societies Dr. Kamal Kant Kohli10 Aug 2023 9:15 AM ISTUSA: The multinational liver societies leaders from La Asociacion Latinoamericana para el Estudio del Hígado (ALEH), American Association for the...
Is Budesonide effective as first-line therapy in autoimmune hepatitis? Jacinthlyn Sylvia12 April 2023 11:15 AM ISTIn a new study, Álvaro Díaz-González and team found that budesonide is rarely used as a first-line therapy and is often only given to individuals who...
MAFLD increases risk of mortality independent of excessive alcohol consumption Jacinthlyn Sylvia23 March 2023 10:00 AM ISTMetabolic dysfunction-associated fatty liver disease (MAFLD) raises the risk of death independently of excessive alcohol use, says an article...
Nonalcoholic fatty liver disease associated with preterm birth: Study Jacinthlyn Sylvia9 Nov 2022 8:00 PM ISTIn a new study conducted by Coralie Amadou and team it was shows the correlation between birth weight (BW) and the prevalence of nonalcoholic fatty...
In elderly patients, fatty liver disease does not impact mortality risk: Study Jacinthlyn Sylvia29 July 2022 7:30 PM ISTNetherlands: In senior people, fatty liver disease may not raise the risk of death, says an article published in Hepatology. The Rotterdam Study data...
Prior decompensation and older age increases HCC risk among cirrhosis patients after HCV infection Jacinthlyn Sylvia19 July 2022 8:10 PM ISTAustralia: Following hepatitis C virus (HCV) treatment, the incidence of hepatocellular carcinoma (HCC) among patients with cirrhosis declines over...
Metformin use lowers hepatocellular cancer risk in NAFLD patients with diabetes: Study Medha Baranwal15 July 2022 8:00 PM ISTUSA: The use of metformin may lower the risk of hepatocellular cancer (HCC) in patients with type 2 diabetes and nonalcoholic fatty liver disease...
Combo of lactulose and rifaximin with amino acids helps treat hepatic encephalopathy: Study Jacinthlyn Sylvia3 Jun 2022 7:30 AM ISTNew Delhi: A recent study showed that a mix of L-ornithine L-aspartate (LOLA) with lactulose and rifaximin was more powerful versus only lactulose and...
Frailty helps predict mortality risk associated with progressive liver cirrhosis: Study Medical Dialogues Editorial Team10 March 2022 9:00 AM ISTCanada: In a new study conducted by Sarah Wang and team, frailty was found to be an independent predictor of progression of cirrhosis or mortality, as...
